Tysabri Half Life

Featured Health Expert
67078
EXPERT

Tysabri: It Comes Down to Choices

An article in the August 1 edition of The Wall Street Journal reports that two patients treated with Tysabri have contracted progressive multifocal leukoencephalopathy (PML) a potentially deadly brain infection. Neither patient has died.

Tysabri was recalled in 2005 because of similar incidents, much to the dismay of many MS patients. At last, there was a new weapon and a new reason for hope in our war against MS. It has been back on the market since July 2006 and, at this time, there are no...

Read more

More information on "Tysabri Half Life"

From Our Experts

See more SharePosts »

From Our Sources

More on Multiple Sclerosis »